Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Immunomodulatory therapy reduces the rate of conversion to generalized myasthenia gravis in seniors with pure ocular myasthenia.

Ocular Myasthenia in Seniors: A Case for Treatment